Bilirubin-induced neurologic damage

New England Journal of Medicine

Volumn 370, Issue 10, 2014, Pages 978-979

  Hegde, Deepraj ^a   Jasani, Bonny ^b   Mutha, Saurabh ^c  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^b KEM HOSPITAL   (India)

^c MANIPAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; FATTY ACID;

CLINICAL FEATURE; DIETARY INTAKE; EVIDENCE BASED MEDICINE; FAT INTAKE; FLUID INTAKE; GESTATIONAL AGE; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; LETTER; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; BILIRUBIN; HUMANS; HYPERBILIRUBINEMIA; KERNICTERUS;

EID: 84895476632     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1315973     Document Type: Letter

References (5)

1. Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage - mechanisms and management approaches. N Engl J Med 2013;369:2021-30.
2. Kerner JA Jr, Poole RL. The use of IV fat in neonates. Nutr Clin Pract 2006;21:374-80.
3. American Academy of Pediatrics Committee on Nutrition. Use of intravenous fat emulsions in pediatric patients. Pediatrics 1981;68:738-43.
4. Amin SB. Effect of free fatty acids on bilirubin-albumin binding affinity and unbound bilirubin in premature infants. JPEN J Parenter Enteral Nutr 2010;34:414-20.
5. Amin SB, Harte T, Scholer L, Wang H. Intravenous lipid and bilirubin-albumin binding variables in premature infants. Pediatrics 2009;124:211-7.